HLN 9.65 Stock Price Haleon plc

Stock List / Haleon plc

Range:	7.89-10.8	Vol Avg:	5690885	Last Div:	0.16	Changes:	0.1
Beta:	0.24	Cap:	43.68B	Currency:	USD	Exchange:	NYSE
Sector:	Healthcare			IPO:	Mon Jul 25 2022	Empoloyees:	25408
CUSIP:	405552100	CIK:	0001900304	ISIN:	US4055521003	Country:	GB
CEO:	Mr. Brian James McNamara			Website:	https://www.haleon.com

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Stock Details

Positive 0.63

Haleon Selects Vistar Media as Preferred Global Partner for Programmatic Out-of-Home (OOH) Advertising

Vistar Media's programmatic OOH technology to enhance Haleon's premium, global media strat...

globenewswire.com·Mon Nov 04 2024

Positive 0.34

Haleon plc (HLN) Q3 2024 Sales Call Transcript

Haleon plc (NYSE:HLN ) Q3 2024 Sales Conference Call October 31, 2024 5:00 AM ET Company P...

seekingalpha.com·Sat Nov 02 2024

Neutral 0.10

Panadol maker Haleon takes hit from currency headwinds

Currency fluctuations meant Haleon PLC (LSE:HLN, NYSE:HLN), the FTSE 100-listed Panadol an...

proactiveinvestors.co.uk·Thu Oct 31 2024

Negative -0.66

Haleon reports marginal decline in third-quarter revenue

Haleon reported a marginal fall in its third-quarter revenue on Thursday, hurt by declines...

reuters.com·Thu Oct 31 2024

Positive 0.44

Haleon gets target hike as UBS raises 'forever' sales target

Haleon PLC (LSE:HLN, NYSE:HLN) has received a price target upgrade from UBS ahead of its t...

proactiveinvestors.co.uk·Wed Oct 09 2024

Neutral 0.00

Futura Medical in line for $5m milestone payment as Haleon's US Eroxon launch gets underway

Futura Medical PLC (AIM:FUM, OTC:FAMDF) has secured a $5 million milestone payment followi...

proactiveinvestors.co.uk·Mon Oct 07 2024

Positive 0.53

HLN or PODD: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already he...

zacks.com·Thu Oct 03 2024

Positive 0.27

Haleon's buy rating restated after Pfizer cuts down stake

UBS has reiterated its buy rating on Haleon PLC (LSE:HLN, NYSE:HLN) shares after news that...

proactiveinvestors.co.uk·Tue Oct 01 2024

Positive 0.30

Haleon buys back some shares as Pfizer sells down stake

Haleon PLC (LSE:HLN, NYSE:HLN) said it has agreed to buy £230 million of its own shares fr...

proactiveinvestors.co.uk·Tue Oct 01 2024

Positive 0.60

Sensodyne maker Haleon to raise stake in China JV

British consumer healthcare company Haleon said on Friday it has agreed to raise its stake...

reuters.com·Fri Sep 27 2024

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.